Comparable Cardiorenal Benefits of SGLT2 Inhibitors and GLP-1RAs in Asian and White Populations
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Comparable Cardiorenal Benefits of SGLT2 Inhibitors and GLP-1RAs in Asian and White Populations: An Updated Meta-analysis of Results From Randomized Outcome Trials
Diabetes Care 2022 Apr 01;45(4)1007-1012, H Tang, SE Kimmel, SM Smith, K Cusi, W Shi, M Gurka, AG Winterstein, J GuoFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.